CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 142 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $358,000 | -72.9% | 69,890 | -62.1% | 0.00% | -100.0% |
| Q2 2019 | $1,322,000 | -45.6% | 184,537 | +0.7% | 0.00% | -50.0% |
| Q1 2019 | $2,432,000 | +57.1% | 183,167 | -6.9% | 0.00% | 0.0% |
| Q4 2018 | $1,548,000 | -33.5% | 196,672 | -6.3% | 0.00% | 0.0% |
| Q3 2018 | $2,327,000 | -9.1% | 209,983 | +10.1% | 0.00% | 0.0% |
| Q2 2018 | $2,560,000 | +55.2% | 190,745 | +50.2% | 0.00% | 0.0% |
| Q1 2018 | $1,649,000 | +50.6% | 126,958 | +6.7% | 0.00% | +100.0% |
| Q4 2017 | $1,095,000 | – | 119,009 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,641,804 | $7,454,000 | 6.54% |
| COMMODORE CAPITAL LP | 2,983,513 | $13,545,000 | 5.40% |
| Foresite Capital Management IV, LLC | 1,787,094 | $8,113,000 | 0.97% |
| Avoro Capital Advisors LLC | 10,300,000 | $46,762,000 | 0.81% |
| Boxer Capital, LLC | 4,000,000 | $18,160,000 | 0.62% |
| Sio Capital Management, LLC | 562,339 | $2,553,000 | 0.52% |
| ACUTA CAPITAL PARTNERS, LLC | 315,341 | $1,432,000 | 0.52% |
| CM Management, LLC | 150,000 | $681,000 | 0.51% |
| APIS CAPITAL ADVISORS, LLC | 120,000 | $545,000 | 0.50% |
| Versant Venture Management, LLC | 543,753 | $2,469,000 | 0.48% |